Zydus Cadila seeks DCGI’s nod for emergency use of its COVID-19 vaccine in India

New Delhi/Bhubaneswar: Zydus Cadila has applied for Emergency Use Authorisation (EUA) seeking approval from the Drugs Controller General of India (DCGI) for the launch of their COVID-19 vaccine in the country for persons of 12 years of age and above.

The DNA vaccine has completed the third phase of trial.

The Centre had recently informed the Supreme Court that Zydus Cadila vaccines have concluded clinical trial for the age group of 12-18 years and these vaccines may be available soon.

Also Read

Comments are closed.

close-link